89 related articles for article (PubMed ID: 20056768)
1. Comment on: Sarcoid-like granulomatosis in patients treated with tumour necrosis factor blockers: 10 cases.
Massara A; Cavazzini L; La Corte R; Trotta F
Rheumatology (Oxford); 2010 May; 49(5):1019-21; author reply 1021-2. PubMed ID: 20056768
[No Abstract] [Full Text] [Related]
2. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases.
Daïen CI; Monnier A; Claudepierre P; Constantin A; Eschard JP; Houvenagel E; Samimi M; Pavy S; Pertuiset E; Toussirot E; Combe B; Morel J;
Rheumatology (Oxford); 2009 Aug; 48(8):883-6. PubMed ID: 19423648
[TBL] [Abstract][Full Text] [Related]
3. [Sarcoid-like granulomatosis in patients treated with anti-TNFα].
Petrovici A; Kaiser MJ; Louis R; Nguyen Dang D
Rev Med Liege; 2016 Mar; 71(3):124-8. PubMed ID: 27311243
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
Izzi S; Francesconi F; Visca P; Altieri A; De Mutiis C; Trevisan G; Bonifati C
Dermatol Online J; 2010 May; 16(5):16. PubMed ID: 20492833
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases.
Ramos-Casals M; Perez-Alvarez R; Perez-de-Lis M; Xaubet A; Bosch X;
Am J Med; 2011 May; 124(5):386-94. PubMed ID: 21531225
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha antagonist-induced sarcoidosis.
Clementine RR; Lyman J; Zakem J; Mallepalli J; Lindsey S; Quinet R
J Clin Rheumatol; 2010 Sep; 16(6):274-9. PubMed ID: 20808167
[TBL] [Abstract][Full Text] [Related]
7. Comment on prescribing tumor necrosis factor inhibitors.
Hanauer LB
Arthritis Rheum; 2002 Jun; 47(3):347-8. PubMed ID: 12115169
[No Abstract] [Full Text] [Related]
8. Pulmonary sarcoid-like granulomatosis induced by ipilimumab.
Berthod G; Lazor R; Letovanec I; Romano E; Noirez L; Mazza Stalder J; Speiser DE; Peters S; Michielin O
J Clin Oncol; 2012 Jun; 30(17):e156-9. PubMed ID: 22547608
[No Abstract] [Full Text] [Related]
9. Anti-tumour necrosis factor agents and lipid profile: a class effect?
Garcês SP; Parreira Santos MJ; Vinagre FM; Roque RM; da Silva JA
Ann Rheum Dis; 2008 Jun; 67(6):895-6. PubMed ID: 18474660
[No Abstract] [Full Text] [Related]
10. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report.
Malaviya AN; Kapoor S; Garg S; Rawat R; Shankar S; Nagpal S; Khanna D; Furst DE
J Rheumatol; 2009 Jul; 36(7):1414-20. PubMed ID: 19487263
[TBL] [Abstract][Full Text] [Related]
11. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
12. Infection and anti-tumor necrosis factor-alpha therapy.
Zandman-Goddard G
Isr Med Assoc J; 2003 Nov; 5(11):814-6. PubMed ID: 14650109
[No Abstract] [Full Text] [Related]
13. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents.
Mohan N; Edwards ET; Cupps TR; Slifman N; Lee JH; Siegel JN; Braun MM
J Rheumatol; 2004 Oct; 31(10):1955-8. PubMed ID: 15468359
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha blocker induced tuberculosis.
Kharbanda P; Dagaonkar R; Balakrishnan C; Udwadia ZF
J Rheumatol; 2010 Jul; 37(7):1542; author reply 1543. PubMed ID: 20595292
[No Abstract] [Full Text] [Related]
15. Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-alpha blocking agents: two cases.
Lourari S; Prey S; Livideanu C; Jamard B; Lamant L; Cantagrel A; Paul C
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):967-8. PubMed ID: 19192017
[No Abstract] [Full Text] [Related]
16. [TNF alpha-antagonists in collagen vascular disease].
Manger K; Manger B
Z Rheumatol; 2003 Jun; 62(3):240-5. PubMed ID: 12827400
[TBL] [Abstract][Full Text] [Related]
17. Neurological complications of infliximab.
Tektonidou MG
J Rheumatol; 2007 Jan; 34(1):237; author reply 237-8. PubMed ID: 17216701
[No Abstract] [Full Text] [Related]
18. Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis.
Stokes DG; Kremer JM
Semin Arthritis Rheum; 2003 Aug; 33(1):1-18. PubMed ID: 12920692
[TBL] [Abstract][Full Text] [Related]
19. [Indications and adverse events with the use of anti-TNFalpha agents in pediatric rheumatology: experience of a single center].
de Oliveira SK; de Almeida RG; Fonseca AR; Rodrigues MC; Sztajnbok F; Diniz C
Acta Reumatol Port; 2007; 32(2):139-50. PubMed ID: 17572652
[TBL] [Abstract][Full Text] [Related]
20. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
Mukhtyar C; Luqmani R
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv31-6. PubMed ID: 16239383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]